MDM2 and lymphoma: In most lymphomas, p53 signaling pathway seems to be inactivated or deregulated due to dysfunction or inactivation of wt-p53, resulted mostly by deregulation of its main negative regulator, MDM2, that may facilitate cancer development and progression in several tumor types, including lymphoma [1].